MG

Meenu Grover

Active Director Director DIN 08943926
DIN 08943926 First appointment Nov 2020 Primary industry Life Sciences
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2020
Shareholding value •••• Premium profile

About Meenu Grover

Data last updated:

Meenu Grover is a Director at Lion Nursery And Chakor Biotech Private Limited (since 2020). The company operates in Life Sciences. Lion Nursery And Chakor Biotech Private Limited reported revenue of ₹2.6 Lakh (FY 2024).

DIN 08943926
Primary Designation Director
Industry Life Sciences
First Appointment 02 Nov 2020
Oldest Company Age 5 yrs
Largest company Lion Nursery And Chakor Biotech Private Limited · ₹2.6 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Nov 20202020₹2.6 Lakh (FY 2024)Active

Board colleagues of Meenu Grover

Directorship timeline

Open interactive timeline →
Lion Nursery And Chakor Biotech Private Limited
Premium access

Shareholding and investment profile for Meenu Grover

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meenu Grover

Meenu Grover currently holds 1 directorship: Lion Nursery And Chakor Biotech Private Limited (Director, since 02 Nov 2020, revenue ₹2.6 Lakh (FY 2024)).

Meenu Grover was first appointed on 02 Nov 2020 as Director at Lion Nursery And Chakor Biotech Private Limited.

The current boards of Meenu Grover's companies include Sher Singh Saini (Lion Nursery And Chakor Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available